These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7511271)

  • 1. [Significance of numerical chromosome aberrations in prostate cancer].
    Henke RP; Krüger E; Ayhan N; Hübner D; Hammerer P
    Verh Dtsch Ges Pathol; 1993; 77():133-7. PubMed ID: 7511271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and distribution of numerical chromosomal aberrations in prostatic cancer.
    Henke RP; Krüger E; Ayhan N; Hübner D; Hammerer P
    Hum Pathol; 1994 May; 25(5):476-84. PubMed ID: 8200641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
    Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numerical chromosomal changes in high-grade prostatic intraepithelial neoplasia (PIN) and concomitant invasive carcinoma.
    Erbersdobler A; Gürses N; Henke RP
    Pathol Res Pract; 1996 May; 192(5):418-27. PubMed ID: 8832746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
    Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
    Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization.
    Baretton GB; Valina C; Vogt T; Schneiderbanger K; Diebold J; Löhrs U
    Cancer Res; 1994 Aug; 54(16):4472-80. PubMed ID: 8044798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
    Takahashi S; Qian J; Brown JA; Alcaraz A; Bostwick DG; Lieber MM; Jenkins RB
    Cancer Res; 1994 Jul; 54(13):3574-9. PubMed ID: 8012984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
    Van Dekken H; Krijtenburg PJ; Alers JC
    Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
    Gburek BM; Kollmorgen TA; Qian J; D'Souza-Gburek SM; Lieber MM; Jenkins RB
    J Urol; 1997 Jan; 157(1):223-7. PubMed ID: 8976257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
    Kobayashi M; Ishida H; Shindo T; Niwa S; Kino M; Kawamura K; Kamiya N; Imamoto T; Suzuki H; Hirokawa Y; Shiraishi T; Tanizawa T; Nakatani Y; Ichikawa T
    Prostate; 2008 Dec; 68(16):1715-24. PubMed ID: 18781578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes.
    Zitzelsberger H; Szücs S; Weier HU; Lehmann L; Braselmann H; Enders S; Schilling A; Breul J; Höfler H; Bauchinger M
    J Pathol; 1994 Apr; 172(4):325-35. PubMed ID: 8207613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
    Qian J; Bostwick DG; Takahashi S; Borell TJ; Herath JF; Lieber MM; Jenkins RB
    Cancer Res; 1995 Nov; 55(22):5408-14. PubMed ID: 7585610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of chromosomal aberration using fluorescence in situ hybridization in DNA diploid colorectal carcinomas].
    Jibiki M; Tagawa Y; Miyashita K; Hara S; Yasutake T; Nakazaki T; Obatake M; Sawai T; Morinaga M; Akama F
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):759-62. PubMed ID: 8489281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic cancer.
    Alers JC; Krijtenburg PJ; Vissers CJ; Bosman FT; van der Kwast TH; van Dekken H
    Cytometry; 1995 Sep; 21(1):84-94. PubMed ID: 8529477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
    Takahashi S; Alcaraz A; Brown JA; Borell TJ; Herath JF; Bergstralh EJ; Lieber MM; Jenkins RB
    Clin Cancer Res; 1996 Jan; 2(1):137-45. PubMed ID: 9816100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.